SUMMARY Thirty three patients with rheumatoid arthritis (RA) treated only with non-steroidal anti-inflammatory drugs were divided into two groups according to the drug received (group A: diclofenac, group B: indomethacin or ketoprofen), and their polymorphonuclear (PMN) cell functions were investigated. We found that bactericidal ability was the only function significantly impaired in group A as compared with group B patients and normal controls. This modification correlated well with the reduction of control PMN bactericidal ability when this test was carried out in patient plasma. These differences between drug effects might explain some of the discrepancies between reports of PMN cell functions in RA.
The role of polymorphonuclear (PMN) cells in inflammation in general,' and in rheumatic diseases in particular,2 has been comprehensively reviewed.
Studies on the functional state of PMN cells in rheumatoid arthritis (RA) have produced conflicting results, however, and a general consensus concerning the nature of the PMN defect has not yet been reached. For example, Howe et al reported impaired chemotaxis in some patients with RA,3 and Gale et al showed that PMN chemiluminescence was activated by rheumatoid serum and synovial fluid. 4 Wilton et al found impaired phagocytosis,5 whereas Wandall found it to be normal. 6 It seems reasonable to suggest that these discrepancies may be due to differences in drug regimens.
In an attempt to test this we selected two groups of patients with RA who differed only in their drug treatment. Each group of patients was receiving only one non-steroidal anti-inflammatory drug (NSAID). In the light of the results we suggest that the differences between the PMN functions in the two groups of patients are due to differences in NSAID treatment.
Patients and methods

PATI ENTS
Thirty three patients were included in the study, all 
Results
As shown in Fig. 1 bactericidal ability was significantly depressed in patients treated with diclofenac, as opposed to those treated with other NSAIDs and to normal controls. Control PMN bactericidal ability was significantly reduced in group A patient plasma (Fig. 2) . No significant overall impairment could be detected in group B patient plasma, although PMN cell killing of bacteria was decreased when incubated in the plasma of eight patients. These patients were receiving high doses of indomethacin (two cases) or ketoprofen (six cases). When the patients were considered as a whole (Fig. 3) , however, their PMN bactericidal activity correlated well with the control PMN bactericidal activity decrease in patient plasma. This PMN function was the only one affected (Fig. 4) As folic acid levels are depressed in the serum of patients with RA22 it is possible that a decline in PMN functions is related to folic acid deficiency. We have previously reported that folic acid deficiency can reduce to a significant degree bacterial engulfment and PMN bactericidal ability. 23 In this study, however, there was no difference in the folic acid levels between the groups of patients, and phagocytosis was found to be normal.
Whatever the mechanism involved, these results point to the need to take account of drug treatment when studying cellular functions in patients with RA. 24 In addition to NSAIDs we have previously shown that D-penicillamine affects PMN chemotaxis. It is probable that some of the conflicting results in the literature may be explained in this way. 
